Blog by Sanwariya Packaging

Your Trusted Partner in Packaging

Learn About Our Vision for the Future And Grow with Us.

Your Trusted Partner in Pharma Packaging

Learn about our vision for the future and grow with us.

Your Trusted Partner
in Pharma Packaging

Learn about our vision for the future and grow with us.

Know More

Tag: track and trace

How foil protects light-sensitive pharmaceuticals from UV exposure

Pharmaceutical supply chains are becoming increasingly complex and global. Medicines now move across multiple countries, distribution hubs, and pharmacies before reaching the patient. To ensure product authenticity and prevent counterfeit medicines from entering the market, regulators around the world have strengthened track-and-trace requirements.

Serialization has become a central part of these regulatory frameworks. Each medicine package must carry a unique identification code that allows it to be traced throughout the supply chain. While serialization is often associated with cartons and labels, printed blister foils also play an important role in supporting traceability.

As regulatory expectations continue to evolve, pharmaceutical companies must ensure that serialization on pharma foils is compatible with modern coding systems, scanning technologies, and global standards such as those published by https://www.gs1.org/.

This blog explains how serialization applies to printed foils, the role of variable data printing, the importance of print alignment accuracy, and the verification processes required to maintain reliable track-and-trace systems in 2026.

Why Serialization Matters in Pharmaceutical Packaging

Serialization allows every medicine package to carry a unique identifier that distinguishes it from all other packages in the market. This identifier is typically encoded in a machine-readable barcode or data matrix symbol.

By scanning this code at different stages of the supply chain, companies can verify the authenticity of the medicine and confirm that it has not been diverted or tampered with.

Serialization supports several important objectives within pharmaceutical supply chains.

  • prevention of counterfeit medicines entering legitimate distribution channels
  • Improved product traceability across international markets
  • Faster identification and recall of affected batches if quality issues arise
  • Enhanced regulatory oversight of pharmaceutical distribution
Many countries now require serialized product identifiers as part of their pharmaceutical regulations. Examples include the European Union Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act, which are widely referenced in global serialization frameworks.

Understanding GS1 Standards and Aggregation

Global serialization systems rely heavily on standardized identification formats. The GS1 system provides internationally recognized standards that allow pharmaceutical companies, distributors, and regulators to exchange product identification data reliably.

These standards define the structure of identifiers such as the Global Trade Item Number (GTIN), batch numbers, expiration dates, and serial numbers.

More information about these identification standards can be found at https://www.gs1.org/standards.

Aggregation is another important concept in serialization. It refers to the digital link between individual product units and the higher packaging levels that contain them.

For example:

  • A serialized blister pack may be linked to a carton
  • Multiple cartons may be linked to a shipping case
  • Several cases may be linked to a pallet
This hierarchical relationship allows supply chain participants to track product movement more efficiently while maintaining visibility at every packaging level.

Variable Data Printing on Blister Foils

Serialization requires packaging systems capable of printing variable information. Unlike static graphics printed during foil production, serialized data must change from one package to the next.

Variable data printed on blister foils may include:

  • Batch numbers
  • Expiry dates
  • Production codes
  • Machine-readable symbols or codes

These markings must remain legible throughout the product’s shelf life and must withstand handling, transportation, and environmental exposure.

Packaging development teams therefore work closely with printing specialists to ensure that the foil surface, coating, and print process support reliable variable data printing.

The available print area on the blister foil must also be carefully designed so that serialized information does not interfere with other regulatory text or branding elements.

Print Alignment and Registration Tolerance

Accurate print alignment is essential when serialization data is applied to blister packaging.

During high-speed packaging operations, even small variations in print registration can affect the placement of variable data on the foil. If the printed code shifts outside the designated area, scanning equipment may not be able to read it correctly.

Packaging engineers therefore define acceptable print alignment tolerances to ensure that variable data remains within the readable zone of the blister pack.

These tolerances are influenced by several factor:.

  • Foil material stability during printing
  • Machine speed during packaging operations
  • Precision of printing and coding systems
  • Alignment between forming cavities and printed graphics

Maintaining consistent print registration is critical to ensure that serialized codes remain both visible and scannable.

Verification and Scanning in Serialized Packaging

Printing serialized data is only part of the track-and-trace process. Pharmaceutical companies must also verify that the printed codes are accurate and readable.

Verification systems typically use automated scanners positioned along the packaging line. These scanners inspect each package to confirm that the serialized code meets required quality parameters.

Typical verification checks include:

  • Correct code structure and formatting
  • Barcode or data matrix readability
  • Correct placement of the code on the packaging surface
  • Matching of printed data with the central serialization database
If a code fails verification, the affected package is automatically rejected from the production line. This process helps ensure that only properly serialized products enter the distribution chain.

Designing Serialization-Ready Printed Foils

As serialization requirements expand globally, packaging development teams increasingly consider serialization during the design stage of printed foils.

Several design factors help support reliable serialization, like:

  • Sufficient blank space reserved for variable data
  • High-contrast background areas that improve code readability
  • Print coatings compatible with inkjet or laser coding technologies
  • Stable foil structures that maintain print alignment during packaging
For high-barrier or compackaging material consistency and printing compatibility play an important role in maintaining reliable serialization performance during production, supported by robust manufacturing capabilities such as those outlined in the infrastructure.evaluated to ensure both protection and print stability.

When these design elements are incorporated early in the packaging development process, serialization implementation becomes significantly more efficient.

Challenges in High-Speed Serialization

Modern pharmaceutical packaging lines operate at very high speeds. Maintaining accurate variable data printing under these conditions can present several technical challenges.

Possible challenges include:

  • Misalignment between printed graphics and blister cavities
  • Inconsistent code contrast due to surface reflections
  • Ink adhesion issues on certain foil coatings
  • Scanning errors caused by distorted or incomplete codes

To overcome these challenges, companies often conduct extensive line trials before launching serialized packaging at commercial scale.

Packaging material consistency and printing compatibility play an important role in maintaining reliable serialization performance during production, supported by robust manufacturing capabilities such as those outlined in the infrastructure.

Regulatory Documentation and Compliance

Regulatory authorities expect pharmaceutical companies to maintain clear documentation demonstrating that their serialization systems are functioning correctly.

This documentation may include:

  • Validation reports for coding and scanning equipment
  • Records of serialization data generation and management
  • Verification system performance data
  • Traceability documentation linking packaging levels
Maintaining accurate records helps companies demonstrate compliance during regulatory inspections and supports transparency within global supply chains.

Strengthening Pharmaceutical Traceability

Serialization has become one of the most important tools for protecting medicine supply chains. By assigning unique identifiers to individual packages, pharmaceutical companies can maintain visibility across global distribution networks and quickly identify potential risks.

Serialization on pharma foils supports these efforts by ensuring that blister packaging remains compatible with modern coding, verification, and scanning systems.

As pharmaceutical serialization requirements continue to evolve in 2026 and beyond, packaging materials must be designed with track-and-trace compatibility in mind.

Sanwariya Packaging manufactures pharmaceutical aluminum foils designed to support high-quality printing, reliable code placement, and compatibility with modern packaging technologies. With advanced printing capabilities and controlled processes supported by its infrastructure, Sanwariya Packaging helps pharmaceutical companies implement serialization-ready blister packaging that supports regulatory compliance and secure global distribution.For further discussions or project requirements, you can get in touch with us or directly request a quote.

Pharma Packaging Mistakes Exporters Still Make

In pharmaceutical exports, packaging is far more than an afterthought — it’s a regulatory gatekeeper. A single misstep in materials, labeling, or serialization can lead to shipment rejections, compliance failures, or even patient safety risks.

Unfortunately, many exporters still repeat critical packaging mistakes that cost them valuable time, money, and brand trust. This blog outlines the six most common errors — and how to avoid them with practical, compliance-aligned solutions.

“Up to 70% of pharma export rejections involve packaging-related errors.” — WHO Compliance Brief, 2023

Common Mistakes to Avoid in Export Pharma Packaging

  • Wrong foil for Zone IV climates
  • Ignoring local packaging regulations
  • Poor serialization or aggregation
  • Incomplete patient instructions
  • Missing validation/testing reports
Fix: Validate packaging, localize labeling, and document everything.

Learn more about how barrier-grade foil protects blister seal integrity in export climates.

1. Material Mismatch: The Wrong Foil for the Wrong Climate

Exporters often select standard foil laminates without considering regional climate conditions — a decision that can compromise product integrity.

For instance, destinations like Brazil or Nigeria fall under ICH Zones IVa/IVb, where high heat and humidity are the norm. If the foil lacks proper moisture vapor transmission (MVTR) or oxygen barrier properties, medicines can degrade during transit or shelf life.

Solution: Validate all packaging materials, especially blister foils, against destination-specific ICH climatic zone data. Ensure sealing parameters are optimized for those conditions.

2. Ignoring Country-Specific Regulatory Requirements

What complies in India may be non-compliant in Brazil, Russia, or the EU. Exporters often miss key packaging mandates:

  • Russia (Chestny ZNAK): Requires serialization and aggregation for all medicinal products.
  • Brazil (ANVISA): Mandates GS1-standard 2D barcodes and traceability submissions.
  • Europe (EU FMD): Demands tamper-evidence and a unique identifier (UI) for prescription medicines.
Mistake: Relying on generic packaging templates or skipping regional compliance audits.

Solution: Work with regulatory specialists or experienced suppliers who understand localized compliance. Adapt packaging lines accordingly.

3. Underestimating Transit Stress & Environmental Conditions

Pharma packaging that performs well in warehouse conditions may fail during global transit due to:

  • Repeated loading/unloading
  • Exposure to heat or condensation
  • Rough handling at ports and airports
Microleaks in blisters or poor laminate adhesion can cause contamination or potency loss.

Solution: Simulate real-world conditions using ICH stability studies (Zone IVb) and transport validation protocols. Test for seal integrity, barrier performance, and container closure integrity (CCI).

4. Serialization Errors and Traceability Gaps

Serialization is no longer optional — yet exporters still fall into traps like:

  • Misaligned barcodes or unreadable QR codes
  • Incomplete aggregation hierarchy (primary → secondary → tertiary)
  • Serialization systems that don’t integrate with local authority databases
Result: Failed inspections, customs clearance delays, and brand credibility damage.

Solution: Use high-resolution printing systems with secure inks and contrast optimization. Collaborate with foil vendors that support serialization-friendly printing and offer tamper-evident features.

5. Poor Localization of Language, Labeling & Instructions

Even technically compliant packaging can fail due to poor localization:

  • Wrong dosage unit (e.g., mg vs. mcg)
  • Incomplete patient warnings
  • Misinterpretation due to non-local terminology
Consequence: Patient misuse, regulatory penalties, or product recalls.

Solution: Localize all label elements, including drug names, storage conditions, and usage instructions. Review country-specific labeling regulations in detail.

6. Inadequate Documentation & Validation

A lack of robust documentation can halt shipments or fail audits:

  • Missing batch records or sealing validations
  • No verification of tamper-evidence
  • Absence of peel strength or vacuum leak test reports
Regulatory authorities demand full traceability — from printed foil to final shipper.

Solution: Implement GMP-aligned packaging validation, including:

  • Dye ingress & vacuum leak testing
  • Peel strength analysis
  • Tamper-evidence verification

Ensure all testing is documented and auditable.

Best Practices for Export-Ready Packaging

To avoid these pitfalls, pharma exporters should:

  • Conduct climate-specific risk assessments
  • Work with specialized foil suppliers for serialization & compliance support
  • Standardize validation protocols and maintain complete QA documentation
  • Train teams on evolving global regulations
  • Audit packaging under realistic transport simulations

Your Packaging is Your Passport

In global pharma logistics, packaging does more than protect — it represents your compliance, your credibility, and your commitment to patient safety.

One overlooked regulation or mismatched foil can jeopardize months of manufacturing and market access. That’s why export packaging demands precision, foresight, and verified quality.

At Sanwariya Packaging, we support pharma exporters with:

  • High-barrier aluminum foils tailored to climate zones
  • Serialization-ready printing with tamper-evidence and regulatory compliance
  • End-to-end documentation and validation support
  • Region-specific guidance for global shipments

Partner with us to safeguard your global supply chain — from formulation to final market.

Ensure seamless pharma exports to Latin America and Russia–CIS. Navigate serialization, anti-counterfeit mandates, and packaging laws with Sanwariya’s regulation-ready solutions.
Ensure seamless pharma exports to Latin America and Russia–CIS. Navigate serialization, anti-counterfeit mandates, and packaging laws with Sanwariya’s regulation-ready solutions.

In today’s global pharmaceutical landscape, packaging compliance isn’t a checkbox — it’s your entry pass. With Latin America and the Russia–CIS region emerging as high-potential markets, exporters must prepare for unique packaging regulations shaped by serialization mandates, multi-language labeling, anti-counterfeit features, and regional barcode standards.

This guide breaks down what it takes to confidently ship compliant pharmaceutical products to these dynamic regions — and how Sanwariya Packaging can support you at every step.

Understand the Regulatory Landscape

1. Latin America

Composed of key pharma markets like Brazil, Argentina, and Colombia, the region is regulated by national authorities such as:

  • ANVISA (Brazil)
  • ANMAT (Argentina)
  • INVIMA (Colombia)

2. Russia–CIS

Led by Roszdravnadzor (Russia) and governed under the Eurasian Economic Union (EAEU), these countries follow regionally aligned packaging and serialization protocols.

Each market enforces distinct requirements — making localized packaging expertise essential.

Compliance Snapshot: Latin America vs Russia–CIS

Regulatory FactorLatin AmericaRussia–CIS
Labeling LanguageSpanish or Portuguese (country-specific)Russian + local EAEU language (where applicable)
SerializationMandatory in Brazil (GS1 standard)Mandatory via Chestny ZNAK, Russia’s national track & trace system
Anti-CounterfeitNot mandated, but advanced features are encouragedTamper-evident and serialized packaging is legally required
Barcode StandardsVary by country; Brazil uses GS1 DataMatrixMandatory DataMatrix, linked to government-regulated platforms
Regulatory OversightANVISA, ANMAT, INVIMA, etc.Roszdravnadzor, EAEU Technical Committees

Top Challenges for Exporters

  • Fragmented Standards –Latin America requires country-specific packaging and label formats. Uniform solutions often fall short.
  • Serialization Mismatch – Brazil uses GS1, while Russia mandates Chestny ZNAK — two very different systems.
  • Language Errors – Missing technical terms or poorly translated medical details can lead to customs rejections.
  • Barcode Placement Issues – A 2mm error in barcode position or font size can delay approvals or lead to regulatory penalties.

How to Ensure Region-Ready Compliance

1. Work with Regulatory-Focused Packaging Partners

Collaborate with suppliers like Sanwariya Packaging, who are fluent in region-specific laws and technical nuances.

2. Use Flexible, Multi-Market Designs

Opt for packaging templates built to accommodate different label languages, serialization formats, and anti-counterfeit elements.

3. Deploy Serialization-Ready Printing

Invest in GS1-compliant and Chestny ZNAK-ready print systems — including high-precision DataMatrix and tamper-evident features.

4. Test with Local Compliance Experts

Validate final packaging with local auditors or consultants before launch to prevent errors and costly delays.

From Hurdle to Opportunity: Make Compliance a Competitive Edge

“The real cost isn’t compliance — it’s non-compliance.”

Compliance is no longer a burden — it’s your brand advantage. With Sanwariya’s support, you gain:

  • Faster product approvals
  • Fewer returns or repackaging costs
  • Stronger regulatory trust
  • Export-readiness across multiple geographies

Pharmaceutical packaging compliance in Latin America and Russia–CIS demands precision, expertise, and proactive execution. With regulatory frameworks tightening across both regions, exporters can no longer afford to treat compliance as an afterthought.

At Sanwariya Packaging, we specialize in high-performance, regulation-ready aluminum foil solutions — tailored for the global pharma landscape. From multi-language labeling and GS1 serialization to Chestny ZNAK compliance and tamper-evident printing, we make sure your packaging meets every requirement the first time.

Exporting to Latin America or Russia–CIS?
Let Sanwariya Packaging ensure your compliance — and your confidence.

Contact us today for tailor-made foil packaging solutions that protect your product, reputation, and global reach.